Paper35488142
Plants as Sources of Natural and Recombinant Antimalaria Agents.
Habibi P and 3 others. Mol Biotechnol, 2022. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Plants as Sources of Natural and Recombinant Antimalaria Agents. Papers, record 35488142. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35488142
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Artemisinins | Major topic |
| Communicable Diseases | Major topic |
| Insecticides | Major topic |
| Malaria | Major topic |
| Plants, Medicinal | Major topic |
| Vaccines | Major topic |
| Humans |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17174271 | Antimalarial properties of green tea. | Biochem Biophys Res Commun | 2007 | https://conductscience.org/library/papers/17174271 | PubMed |
| 2 | 20051036 | Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. | Plant Biotechnol J | 2010 | https://conductscience.org/library/papers/20051036 | PubMed |
| 3 | 28049347 | Strategies to enhance biologically active-secondary metabolites in cell cultures of Artemisia - current trends. | Crit Rev Biotechnol | 2017 | https://conductscience.org/library/papers/28049347 | PubMed |
| 4 | 15539672 | Traditional herbal medicines for malaria. | BMJ | 2004 | https://conductscience.org/library/papers/15539672 | PubMed |
| 5 | 30200856 | The Promise of a Malaria Vaccine-Are We Closer? | Annu Rev Microbiol | 2018 | https://conductscience.org/library/papers/30200856 | PubMed |
| 6 | 17134389 | Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues. | Plant Biotechnol J | 2004 | https://conductscience.org/library/papers/17134389 | PubMed |
| 7 | 21411014 | Natural products as starting points for future anti-malarial therapies: going back to our roots? | Malar J | 2011 | https://conductscience.org/library/papers/21411014 | PubMed |
| 8 | 22134876 | Bioprocessing of plant-derived virus-like particles of Norwalk virus capsid protein under current Good Manufacture Practice regulations. | Plant Cell Rep | 2012 | https://conductscience.org/library/papers/22134876 | PubMed |
| 9 | 15504827 | Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15504827 | PubMed |
| 10 | 32423415 | The potential of anti-malarial compounds derived from African medicinal plants: a review of pharmacological evaluations from 2013 to 2019. | Malar J | 2020 | https://conductscience.org/library/papers/32423415 | PubMed |
| 11 | 21281425 | Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. | Plant Biotechnol J | 2011 | https://conductscience.org/library/papers/21281425 | PubMed |
| 12 | 20162091 | Medicinal plants useful for malaria therapy in Okeigbo, Ondo State, Southwest Nigeria. | Afr J Tradit Complement Altern Med | 2006 | https://conductscience.org/library/papers/20162091 | PubMed |
| 13 | 18551251 | Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice. | Pharm Res | 2008 | https://conductscience.org/library/papers/18551251 | PubMed |
| 14 | 3284455 | Activity of a combination of three cinchona bark alkaloids against Plasmodium falciparum in vitro. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3284455 | PubMed |
| 15 | 22158354 | Generation of the potent anti-malarial drug artemisinin in tobacco. | Nat Biotechnol | 2011 | https://conductscience.org/library/papers/22158354 | PubMed |
| 16 | 19781007 | Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system. | Plant Biotechnol J | 2009 | https://conductscience.org/library/papers/19781007 | PubMed |
| 17 | 24573443 | Bioreactors for plant cells: hardware configuration and internal environment optimization as tools for wider commercialization. | Biotechnol Lett | 2014 | https://conductscience.org/library/papers/24573443 | PubMed |
| 18 | 17317057 | Uses and abuses of in vitro tests in ethnopharmacology: visualizing an elephant. | J Ethnopharmacol | 2007 | https://conductscience.org/library/papers/17317057 | PubMed |
| 19 | 24602358 | The potential of anti-malarial compounds derived from African medicinal plants, part II: a pharmacological evaluation of non-alkaloids and non-terpenoids. | Malar J | 2014 | https://conductscience.org/library/papers/24602358 | PubMed |
| 20 | 29355852 | Drug resistance in Plasmodium. | Nat Rev Microbiol | 2018 | https://conductscience.org/library/papers/29355852 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737792 | Antiplasmodial Compounds from Eurycoma harmandiana Pierre and Eurycoma longifolia Jack Against Drug-Resistant Plasmodium falciparum: An Integrated In Vitro and In Silico Study. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737792 | PubMed |
| 42344326 | Multifaceted anti-infective efficacy of Alstonia scholaris (Mizoram chemotype) against fungal, malarial, and intestinal helminth pathogens: in vitro validation and molecular docking insights. | Vet World | 2026 | https://conductscience.org/library/papers/42344326 | PubMed |
| 42130842 | Novel sugar-conjugated Knoevenagel condensate curcumin derivatives as promising bioactive hybrids with antimalarial potential. | RSC Adv | 2026 | https://conductscience.org/library/papers/42130842 | PubMed |
| 41301879 | First Evidence of Anti-Plasmodium vivax (Plasmodiidae): Activity of the Essential Oil and 6-Ishwarone Isolated from Piper alatipetiolatum Yunck. (Piperaceae). | Biomedicines | 2025 | https://conductscience.org/library/papers/41301879 | PubMed |
| 40627280 | Prophylactic and Curative Potency of Xylopia aethiopica "(Dunal) A. Rich." Leaf Extract on Mice Malaria Parasite (Plasmodium berghei). | Acta Parasitol | 2025 | https://conductscience.org/library/papers/40627280 | PubMed |
| 40093582 | Plant-derived Bisphenol C is a drug candidate against Nipah henipavirus infection: an in-vitro and in-silico study of Pouzolzia zeylanica (L.) Benn. | In Silico Pharmacol | 2025 | https://conductscience.org/library/papers/40093582 | PubMed |
| 39860227 | Ellagic Acid from Geranium thunbergii and Antimalarial Activity of Korean Medicinal Plants. | Molecules | 2025 | https://conductscience.org/library/papers/39860227 | PubMed |
| 39185312 | Plant-based nanoparticles targeting malaria management. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39185312 | PubMed |
| 38734650 | Phytochemical evaluation of Ziziphus mucronata and Xysmalobium undulutum towards the discovery and development of anti-malarial drugs. | Malar J | 2024 | https://conductscience.org/library/papers/38734650 | PubMed |
| 38206944 | Assessment of antimalarial activity of crude extract of Chan-Ta-Lee-La and Pra-Sa-Chan-Dang formulations and their plant ingredients for new drug candidates of malaria treatment: In vitro and in vivo experiments. | PLoS One | 2024 | https://conductscience.org/library/papers/38206944 | PubMed |
| 38144436 | The Global Impact of COVID-19: Historical Development, Molecular Characterization, Drug Discovery and Future Directions. | Clin Pathol | 2023 | https://conductscience.org/library/papers/38144436 | PubMed |
| 38078091 | Recent advances in expression and purification strategies for plant made vaccines. | Front Plant Sci | 2023 | https://conductscience.org/library/papers/38078091 | PubMed |
| 37111366 | Curcumin and Its Derivatives as Potential Antimalarial and Anti-Inflammatory Agents: A Review on Structure-Activity Relationship and Mechanism of Action. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37111366 | PubMed |
| 37074472 | Cuscuta reflexa Possess Potent Inhibitory Activity Against Human Malaria Parasite: An In Vitro and In Vivo Study. | Curr Microbiol | 2023 | https://conductscience.org/library/papers/37074472 | PubMed |
| 36879244 | Senna occidentalis (L.) Link root extract inhibits Plasmodium growth in vitro and in mice. | BMC Complement Med Ther | 2023 | https://conductscience.org/library/papers/36879244 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CTBS | 1486 | PubTator's text mining | https://conductscience.org/library/genes/1486 | NCBI Gene |
| DNAJC5 | 80331 | PubTator's text mining | https://conductscience.org/library/genes/80331 | NCBI Gene |
| PCYT1B | 9468 | PubTator's text mining | https://conductscience.org/library/genes/9468 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35488142
GET https://conductscience.org/api/papers/v1/35488142/references?page=2